Imperial College London

ProfessorEricAlton

Faculty of MedicineNational Heart & Lung Institute

Chair in Gene Therapy
 
 
 
//

Contact

 

+44 (0)20 7594 7929e.alton

 
 
//

Assistant

 

Miss Samia Soussi +44 (0)20 7594 7980

 
//

Location

 

Emmanuel Kaye BuildingRoyal Brompton Campus

//

Summary

 

Summary

Eric Alton is Professor of Gene Therapy and Respiratory Medicine, National Heart & Lung Institute, Imperial College London and Honorary Consultant Physician, Royal Brompton Hospital

Professor Alton was educated at Jesus College, Cambridge and Westminster Medical School and subsequently undertook six years of general medical training.  Over the last fifteen years, he has been involved in developing gene therapy for cystic fibrosis and angiogenesis, including three clinical trials.

Professor Alton coordinates the UK CF Gene Therapy Consortium which brings together the three centres in the UK (Edinburgh and Oxford Universities and Imperial College), including approximately 80 clinicians and scientists focused on this problem.

 

Publications

Journals

Davies J, Morales S, Alton E, et al., 2023, Lytic bacteriophage is a promising adjunct to common antibiotics across cystic fibrosis clinical strains and culture models of Pseudomonas aeruginosa infection, Antibiotics, Vol:12, ISSN:2079-6382, Pages:1-14

Conference

Bell RV, Clarke NK, Alton EWFW, et al., 2022, Regulated expression of secreted transgenes by pulmonary transplanted macrophages in mice, 29th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy (ESCGT), MARY ANN LIEBERT, INC, Pages:A55-A55, ISSN:1043-0342

Sinadinos A, Bell R, Meng C, et al., 2022, A lentiviral vector intranasal dosing strategy to control local and systemic expression of intracellular and secreted transgenic proteins in vivo, 29th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy (ESCGT), MARY ANN LIEBERT, INC, Pages:A195-A195, ISSN:1043-0342

Richardson VR, Clarke NK, Griesenbach U, et al., 2022, Optimising the genetic modification of macrophages using a lentiviral vector for application in cellular therapies, 29th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy (ESCGT), MARY ANN LIEBERT, INC, Pages:A43-A43, ISSN:1043-0342

Juarez-Molina C, Meng C, Morgan C, et al., 2022, Non-viral Gene Therapy for Autoimmune Pulmonary Alveolar Proteinosis, 29th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy (ESCGT), MARY ANN LIEBERT, INC, Pages:A189-A189, ISSN:1043-0342

More Publications